05-08-21 FSC Looking Bought, Patent Owners Distraught

This week Kyle and Dan discuss round three of the GME hearings with the Financial Services Commission, the Biden administration's attempts to nationalize vaccine patents, and the new IBM 2 nanometer processor chips. In investing, Dan's long terms stay sideways and Kyle goes over AMC's recent earnings call. For trading, Dan finally gets put some AMC shares and Kyle closes out some losing positions. For the bet, someone jumps out to a large early lead! If you like our show, please let us know by rating and subscribing on your platform of choice!Should you like our show and hate social media, then please tell all your friends!If you have no friends and hate social media and you just want to give us money for advertising and help you find more friends, then you can donate here!SponsorshipsThis week's Sponsored content (Disclosure Below) is Antibe Therapeutics (TSX: ATE) (OTC: ATBPF). Check out our post here and if you want to learn more, follow this link: Antibe TherapeuticsOur podcast is also sponsored by Sue Pullen at Fairway Independent Mortgage (MLS# 206048). Licensed in 25 states, if you need anything mortgage-related, reach out to her at [email protected] or give her a call at (520) 977-7904. Tell her 2 Bulls sent you to get the best rates available!To contact us, you can email us directly at [email protected] Or leave a message at (725) 22-BULLS. Be sure to follow us on Facebook, Twitter, or Discord to get updated when new content is posted! Links:Financial Services Committee HearingBiden wants to Waive Vaccine PatentsIBM Creates 2nm ProcessorPTON Recall and ApologySPCE Test Flight Scheduled?BRK.A Shares Break QQQ Upper LimitsReddit "Tinfoil Hat" TheoryAMC Earnings CallDiscordhttps://discord.gg/Q8hft2zMTMBeginner Stuff:Intro to the Stock MarketOptions 101Cryptos with Nicholas ProutenCovered Calls How ToKnowledge CenterMonth End Reviews:March 2021DisclosureThrough an agreement with a third party, Financial Ineptitude, Inc was paid $110 on 5/08/21 through 5/10/21 to write this promotional content for Antibe Therapeutics (TSX: ATE) (OTC: ATBPF), which contains affiliate links. We are not licensed to give financial advice and nothing in this article should be construed as such. Please do your own research and consult with a financial advisor before making any investment decisions.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy